Wednesday, April 19, 2006

Speaking of which...


Some of you may know that I've been involved in testing of therapeutics with a company called IBEX. Well my results cought the attention of some journalists at the AACR and a PR was issued. Basically I showed that expression of Kallikreins may modify disease progression in an ovarian cancer model in ways that hadn't been anticipated.


2 comments:

Anonymous said...
This comment has been removed by a blog administrator.
Anonymous Coward said...

censoring is fun....